CD4+ T cells were reported to play a central role in initiating and maintaining anticancer immune responses in human head and neck cancer [40]; meanwhile, they were also reported to correlate with lymph node involvement and unfavorable prognosis in human breast cancers [41]. The gene discussed is CD4; the disease is breast cancer.